• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量低回声病变在预测和 Gleason 分级前列腺癌中的作用:一项前瞻性研究。

Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study.

机构信息

Department of Urology, Yonsei University College of Medicine, 211 Eonjuro, Gangnam-gu, Seoul, 135-720, Korea.

出版信息

World J Urol. 2018 Jul;36(7):1059-1065. doi: 10.1007/s00345-018-2224-8. Epub 2018 Mar 5.

DOI:10.1007/s00345-018-2224-8
PMID:29508049
Abstract

PURPOSE

Hypoechoic lesions are not included as indicators for prostate biopsy. To discriminate the features of hypoechoic lesions, we investigated the ultrasonographic characteristics of hypoechoic lesions using numerical analysis in image. In addition, we evaluated previously suggested subjective parameters on hypoechoic lesion.

METHODS

We performed one-core targeted biopsy (TBx) for each hypoechoic lesion in up to two lesions in each patient before the 12-core systemic biopsy was obtained between July 2015 and May 2016. Image analysis data were analyzed using grayscale values and Hounsfield units (HU) to measure heterogeneity. Subjective evaluation of hypoechoic lesions including hypoechoicity, irregularity, vascularity, and microcalcification was also validated.

RESULTS

Of 157 patients (median age = 67.1 years, median prostate-specific antigen = 6.21 ng/mL) included in the study, 77 (49.0%) were diagnosed with prostate cancer (PCa), and 39 (17.0%) diagnoses were confirmed by the results of targeted cores. The existence of hypoechoic lesions was not a final predictor for PCa detection. In multivariate analysis using a combination of clinical and quantitative image analyses, the grayscale value was identified as a significant predictive factor for the presence of PCa and high-grade disease (Gleason score ≥ 7) on target lesions. The combination of clinical and image variables had the highest area under the curve (0.890) for detecting PCa in TBx.

CONCLUSIONS

The proposed method for the quantitation of hypoechoic lesions using grayscale images and HU is simple. Combined with the current clinical approaches, quantitative scoring of lesions can be useful for detecting PCa and making more precise diagnoses.

摘要

目的

低回声病灶不包括在前列腺活检的指征内。为了区分低回声病灶的特征,我们使用图像的数值分析研究了低回声病灶的超声特征。此外,我们还评估了低回声病灶的先前提出的主观参数。

方法

我们在 2015 年 7 月至 2016 年 5 月期间进行了 12 核心系统活检之前,对每位患者最多两个病灶中的每个低回声病灶进行了 1 核心靶向活检(TBx)。使用灰度值和亨氏单位(HU)分析图像分析数据来测量异质性。还验证了低回声病灶的主观评估,包括低回声、不规则性、血管生成和微钙化。

结果

在研究中包括的 157 名患者(中位年龄为 67.1 岁,中位前列腺特异性抗原为 6.21ng/ml)中,77 名(49.0%)被诊断为前列腺癌(PCa),39 名(17.0%)通过靶向核心的结果得到确诊。低回声病灶的存在不是 PCa 检测的最终预测指标。在使用临床和定量图像分析相结合的多变量分析中,灰度值被确定为靶病灶中存在 PCa 和高级别疾病(Gleason 评分≥7)的显著预测因素。临床和图像变量的组合在 TBx 中检测 PCa 的曲线下面积最高(0.890)。

结论

使用灰度图像和 HU 对低回声病灶进行定量的方法很简单。与当前的临床方法相结合,对病变进行定量评分有助于检测 PCa 并做出更精确的诊断。

相似文献

1
Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study.定量低回声病变在预测和 Gleason 分级前列腺癌中的作用:一项前瞻性研究。
World J Urol. 2018 Jul;36(7):1059-1065. doi: 10.1007/s00345-018-2224-8. Epub 2018 Mar 5.
2
Usefulness of grayscale values measuring hypoechoic lesions for predicting prostate cancer: An experimental pilot study.测量低回声病变的灰度值对预测前列腺癌的效用:一项实验性初步研究。
Prostate Int. 2022 Mar;10(1):28-33. doi: 10.1016/j.prnil.2021.11.002. Epub 2021 Dec 3.
3
Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice.比较在真实世界实践中前列腺特异性抗原水平<10.0ng/ml 的患者采用各种前列腺活检方法的前列腺癌检出率。
Investig Clin Urol. 2020 Jan;61(1):28-34. doi: 10.4111/icu.2020.61.1.28. Epub 2019 Nov 28.
4
Usefulness of grayscale values of hypoechoic lesions matched with target lesions observed on magnetic resonance imaging for the prediction of clinically significant prostate cancer.磁共振成像观察到的低回声病变的灰度值与靶病变匹配对预测临床显著前列腺癌的作用。
BMC Urol. 2022 Oct 29;22(1):164. doi: 10.1186/s12894-022-01111-7.
5
Clinical significance of small (less than 0.2 cm3) hypoechoic lesions in men with normal digital rectal examinations and prostate-specific antigen levels less than 10 ng/mL.
Urology. 1999 Feb;53(2):356-8. doi: 10.1016/s0090-4295(98)00509-3.
6
Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.基于风险的患者选择行 MRI 靶向前列腺活检可避免不必要的 MRI 扫描。此类患者为经直肠超声引导下前列腺随机活检阴性。
Eur Urol. 2016 Jun;69(6):1129-34. doi: 10.1016/j.eururo.2015.11.018. Epub 2015 Dec 2.
7
Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.在未经前列腺活检的患者中进行前列腺癌风险评估:多参数磁共振成像-经直肠超声(TRUS)融合活检和系统 TRUS 活检中的鹿特丹前列腺癌风险计算器。
Eur Urol Oncol. 2018 Jun;1(2):109-117. doi: 10.1016/j.euo.2018.02.010. Epub 2018 May 15.
8
Diagnostic Value of Different Systematic Prostate Biopsy Methods in the Detection of Prostate Cancer with Ultrasonographic Hypoechoic Lesions--A Comparative Study.不同系统性前列腺穿刺活检方法对超声低回声病灶前列腺癌的诊断价值——一项对比研究
Urol Int. 2015;95(2):183-8. doi: 10.1159/000381752. Epub 2015 Jun 20.
9
Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis.在初次活检的患者中,根据 PSA 水平比较 TRUS 引导下活检与 MRI 靶向活检的癌症检出率:倾向评分匹配分析。
Clin Genitourin Cancer. 2019 Feb;17(1):e19-e25. doi: 10.1016/j.clgc.2018.09.007. Epub 2018 Sep 13.
10
Contemporary impact of transrectal ultrasound lesions for prostate cancer detection.经直肠超声检查病变对前列腺癌检测的当代影响。
J Urol. 2004 Aug;172(2):512-4. doi: 10.1097/01.ju.0000131621.61732.6b.

引用本文的文献

1
Machine learning based on radiomics features combing B-mode transrectal ultrasound and contrast-enhanced ultrasound to improve peripheral zone prostate cancer detection.基于放射组学特征的机器学习结合 B 型经直肠超声和对比增强超声提高外周带前列腺癌检测能力。
Abdom Radiol (NY). 2024 Jan;49(1):141-150. doi: 10.1007/s00261-023-04050-5. Epub 2023 Oct 5.
2
Comparative Assessment of Different Ultrasound Technologies in the Detection of Prostate Cancer: A Systematic Review and Meta-Analysis.不同超声技术在前列腺癌检测中的比较评估:一项系统评价与荟萃分析
Cancers (Basel). 2023 Aug 15;15(16):4105. doi: 10.3390/cancers15164105.
3

本文引用的文献

1
Should Hypoechoic Lesions on Transrectal Ultrasound Be Sampled During Magnetic Resonance Imaging-targeted Prostate Biopsy?在磁共振成像靶向前列腺活检过程中,经直肠超声检查发现的低回声病变是否应进行采样?
Urology. 2017 Jul;105:113-117. doi: 10.1016/j.urology.2016.11.012. Epub 2016 Nov 15.
2
Diagnosis and Monitoring of Prostatic Lesions: A Comparison of Three Modalities: Multiparametric MRI, Fusion MRI/Transrectal Ultrasound (TRUS), and Traditional TRUS.前列腺病变的诊断与监测:三种模式的比较:多参数磁共振成像、融合磁共振成像/经直肠超声(TRUS)以及传统TRUS
Cureus. 2016 Jul 18;8(7):e702. doi: 10.7759/cureus.702.
3
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.
A scoring diagnostic system based on biparametric ultrasound features for prostate cancer risk assessment.
一种基于双参数超声特征的前列腺癌风险评估评分诊断系统。
Quant Imaging Med Surg. 2023 Jun 1;13(6):3703-3715. doi: 10.21037/qims-22-1354. Epub 2023 Apr 11.
4
Role of the elastography strain ratio using transrectal ultrasonography in the diagnosis of prostate cancer and clinically significant prostate cancer.经直肠超声弹性成像应变率比值在前列腺癌及临床显著前列腺癌诊断中的作用。
Sci Rep. 2022 Dec 7;12(1):21171. doi: 10.1038/s41598-022-25748-4.
5
Usefulness of grayscale values of hypoechoic lesions matched with target lesions observed on magnetic resonance imaging for the prediction of clinically significant prostate cancer.磁共振成像观察到的低回声病变的灰度值与靶病变匹配对预测临床显著前列腺癌的作用。
BMC Urol. 2022 Oct 29;22(1):164. doi: 10.1186/s12894-022-01111-7.
6
Usefulness of grayscale values measuring hypoechoic lesions for predicting prostate cancer: An experimental pilot study.测量低回声病变的灰度值对预测前列腺癌的效用:一项实验性初步研究。
Prostate Int. 2022 Mar;10(1):28-33. doi: 10.1016/j.prnil.2021.11.002. Epub 2021 Dec 3.
7
Effect of training and individual operator's expertise on prostate cancer detection through prostate biopsy: Implications for the current quantitative training evaluation system.培训和个体操作者专业水平对前列腺穿刺活检中前列腺癌检出率的影响:对现行定量培训评估体系的启示。
Investig Clin Urol. 2021 Nov;62(6):658-665. doi: 10.4111/icu.20210060. Epub 2021 Aug 10.
8
A Nomogram Based on a Multiparametric Ultrasound Radiomics Model for Discrimination Between Malignant and Benign Prostate Lesions.基于多参数超声影像组学模型的列线图用于鉴别前列腺良恶性病变
Front Oncol. 2021 Mar 2;11:610785. doi: 10.3389/fonc.2021.610785. eCollection 2021.
9
Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice.比较在真实世界实践中前列腺特异性抗原水平<10.0ng/ml 的患者采用各种前列腺活检方法的前列腺癌检出率。
Investig Clin Urol. 2020 Jan;61(1):28-34. doi: 10.4111/icu.2020.61.1.28. Epub 2019 Nov 28.
10
Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL?在对前列腺特异性抗原≤10 ng/mL的患者进行系统性前列腺活检以提高前列腺癌检出率时,真的需要进行靶向活检吗?
Medicine (Baltimore). 2019 Dec;98(51):e18505. doi: 10.1097/MD.0000000000018505.
美国国立综合癌症网络(NCCN)指南解读:前列腺癌早期检测,2016年第2版
J Natl Compr Canc Netw. 2016 May;14(5):509-19. doi: 10.6004/jnccn.2016.0060.
4
Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.视觉估计磁共振成像靶向前列腺活检可提高前列腺特异性抗原(PSA)水平<10 ng/mL患者中显著前列腺癌的检出率。
Yonsei Med J. 2016 May;57(3):565-71. doi: 10.3349/ymj.2016.57.3.565.
5
The Establishment of K-CaP (the Multicenter Korean Prostate Cancer Database).K-CaP(韩国多中心前列腺癌数据库)的建立。
Korean J Urol. 2013 Apr;54(4):229-33. doi: 10.4111/kju.2013.54.4.229. Epub 2013 Apr 16.
6
Low-risk prostate cancer patients without visible tumor (T1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol.对于多参数 MRI 上未见肿瘤(T1c)的低危前列腺癌患者,即使不符合主动监测方案的纳入标准,也有资格成为主动监测候选者。
Jpn J Clin Oncol. 2013 May;43(5):553-8. doi: 10.1093/jjco/hyt041. Epub 2013 Apr 11.
7
Is a visible (hypoechoic) lesion at biopsy an independent predictor of prostate cancer outcome?在活检中,可见(低回声)病变是否是前列腺癌结局的独立预测因子?
Ultrasound Med Biol. 2012 Oct;38(10):1689-94. doi: 10.1016/j.ultrasmedbio.2012.06.006. Epub 2012 Aug 21.
8
Evaluating the oncologic outcomes in 152 patients undergoing extraperitoneal laparoscopic radical prostatectomy.评估 152 例行腹膜外腹腔镜根治性前列腺切除术患者的肿瘤学结果。
Chin Med J (Engl). 2012 May;125(9):1529-35.
9
The value of an additional hypoechoic lesion-directed biopsy core for detecting prostate cancer.用于检测前列腺癌的额外低回声病灶靶向活检组织芯的价值。
BJU Int. 2008 Mar;101(6):685-90. doi: 10.1111/j.1464-410X.2007.07309.x.
10
A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.
Eur Radiol. 2006 Apr;16(4):927-38. doi: 10.1007/s00330-005-0035-y. Epub 2006 Jan 4.